Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).
about
Thunder and lightning: immunotherapy and oncolytic viruses collideMolecular genetics of prostate cancer: new prospects for old challengesThe application of exosomes as a nanoscale cancer vaccine.Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoeditingInhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.Immunotherapy of cancer in 2012.Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4The evolving role of dendritic cells in cancer therapy.Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Combination of adjuvants: the future of vaccine design.Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Antigen-specific therapy of rheumatoid arthritis
P2860
Q24597894-E79DA01D-AEFD-4D4F-9877-F9A416A26819Q34127462-7A68A247-F4BC-4E5A-93EC-F035C71F1FCEQ34343272-CA78960D-00AB-4843-83D7-3EC587C76598Q34445188-7CBFE189-F473-4D9D-8942-489A56087058Q36106303-C45E04F5-5508-4445-8442-EEF9BE2B4A6DQ36243536-9EE063D3-515F-4711-93EE-0298D6F2CA34Q37354177-D23E7CEB-7161-4507-B177-CC8C587A9FCEQ37448957-AF819937-C0A5-4C47-9689-D65CB63CFC71Q37513871-60EBC420-734F-4B1F-B972-BFCDC8931CBFQ37687418-B8E80E78-1917-4006-A577-750616B45B9FQ37735454-1A0AA6AA-2B97-448F-B36E-D3FBC5BB4BBBQ38124060-A7E9A7FC-6E0F-42D0-B26C-C18B58BD2292Q39666393-AB53ED46-DA8B-495A-8F9E-CB9BA9FBA405Q41520681-2BF04D22-E1E0-4CCE-A9B4-969243841925Q57674015-CD1A3546-0A44-4E80-B2B7-C234206A8948
P2860
Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunotherapy for prostate can ...... ing cells: APC8015 (Provenge).
@en
type
label
Immunotherapy for prostate can ...... ing cells: APC8015 (Provenge).
@en
prefLabel
Immunotherapy for prostate can ...... ing cells: APC8015 (Provenge).
@en
P2860
P1476
Immunotherapy for prostate can ...... ing cells: APC8015 (Provenge).
@en
P2093
Andrea L Harzstark
Eric J Small
P2860
P304
P356
10.1517/14712598.7.8.1275
P407
P577
2007-08-01T00:00:00Z